Bifidobacterium longum B18 Modulates Pharmacologically Induced Sleep Parameters in Rats in Association with Altered Tryptophan-Melatonin Metabolism
Abstract
Sleep disorders represent a growing public health concern, yet current pharmacological interventions are limited by tolerance, dependence, and rebound insomnia. This study evaluated the probiotic properties of Bifidobacterium longum B18 and its effects on pharmacologically induced sleep parameters in male Sprague-Dawley rats, focusing on tryptophan-related metabolism and gut microbiota composition. In vitro, B18 exhibited favourable probiotic characteristics, no detectable haemolytic activity, and susceptibility to all eight antimicrobials tested. In vivo, B18 significantly shortened barbital sodium-induced sleep latency and prolonged pentobarbital sodium-induced sleep duration (p Bifidobacterium and Lactobacillus in the B18 group than in the DZP group, together with lower Desulfovibrio abundance than in the CTR. Exploratory correlation analysis further showed positive associations of Bifidobacterium abundance with faecal tryptophan and melatonin levels and an inverse association with the Kyn/Trp ratio. Collectively, these findings indicate that B. longum B18 modifies pharmacologically induced sleep parameters in association with altered tryptophan-melatonin metabolism and gut microbiota composition, supporting further evaluation of B18 as a candidate probiotic for sleep-related functional applications.
Read the paper
Related studies
- A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials Evaluating the Evidence Base of Melatonin, Light Exposure, Exercise, and Complementary and Alternative Medicine for Patients with Insomnia Disorder
- Use of Melatonin and/on Ramelteon for the Treatment of Insomnia in Older Adults: A Systematic Review and Meta-Analysis
- Influence of evening light exposure on polysomnographically assessed night-time sleep: A systematic review with meta-analysis
- Use of melatonin in children and adolescents with idiopathic chronic insomnia: a systematic review, meta-analysis, and clinical recommendation
- Significant potential of melatonin therapy in Parkinson’s disease – a meta-analysis of randomized controlled trials
- Meta-Analysis: Melatonin for the Treatment of Primary Sleep Disorders
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.